KMT2A and acute myeloid leukemia: Among the various cytogenetic subtypes of pediatric AML, core binding factor AML (comprising inv(16), t(8;21)), and KMT2A rearranged AML comprised 49% and 40% of samples with mesothelin positivity, respectively.